Cover Image
市場調查報告書

事後緊急避孕藥的全球市場:2016年∼2020年

Global Emergency Contraceptive Pills Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 365979
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
事後緊急避孕藥的全球市場:2016年∼2020年 Global Emergency Contraceptive Pills Market 2016-2020
出版日期: 2016年07月28日 內容資訊: 英文 48 Pages
簡介

全球事後緊急避孕藥市場預測從2016年到2020年間,將以1.93%的年複合成長率 (CAGR) 擴大。

本報告依地區別提供全球事後緊急避孕藥市場現狀分析與今後的預測,再加上市場成長因素與課題,主要國家的趨勢,主要企業分析等資訊。

第1章 摘要整理

  • 概況

第2章 本報告的調查範圍

  • 市場概要
  • 主要供應商的產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場洞察

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 地理區分

  • 南北美洲
  • 歐洲·中東·非洲地區
  • 亞太地區

第7章 主要國家

第8章 市場成長因素

第9章 市場成長因素的影響

第10章 市場課題

第11章 成長因素與課題的影響

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式
  • 其他卓越供應商

第14章 主要供應商分析

  • Allergan
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Piramal Healthcare
  • Teva Pharmaceuticals

第15章 附錄

  • 簡稱清單

第16章 關於Technavio

目錄
Product Code: IRTNTR9341

About Emergency Contraceptive (EC) Pills

EC pills are short-term contraceptives used in the initial days after sexual intercourse to prevent pregnancy due to various uncertainties such as unprotected intercourse, coerced sex, forgotten pills, and condom breakage. These pills are only effective before the fertilization of the ovum by the sperm. As per WHO, levonorgestrel-based EC pills are ideal for users when taken in a single dose. These pills are not effective after five days once the ovulation process begins. Factors such as urbanization, increasing acceptance of sex, and growing visibility of EC pills are increasing their penetration in emerging economies.

Technavio's analysts forecast the global EC pills market to grow at a CAGR of 1.93% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global EC pills market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the retail sales of generic and branded EC pills worldwide. However, the report does not include sales of long-term contraception methods such as birth control pills.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Emergency Contraceptive (EC) Pills Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Allergan
  • Lupin
  • Mankind
  • Piramal
  • Teva

Other Prominent Vendors

  • HLL Life Care
  • Pfizer
  • Syzygy Healthcare
  • V Care Pharma

Market driver

  • Increase in unplanned pregnancies
  • For a full, detailed list, view our report

Market challenge

  • Counterfeit products
  • For a full, detailed list, view our report

Market trend

  • Growing sales of generic brands
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Geographical segmentation

  • EC pills market in Americas
  • EC pills market in EMEA
  • EC pills market in APAC

PART 07: Key leading countries

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 14: Key vendor analysis

  • Allergan
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Piramal Healthcare
  • Teva Pharmaceuticals

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Overview: global EC pills market 2016-2020
  • Exhibit 03: Global EC pills market 2015-2020 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global EC pills market segmentation by geography 2015
  • Exhibit 06: Global EC pills market segmentation by geography 2020
  • Exhibit 07: Global EC pills market segmentation by geography 2015-2020
  • Exhibit 08: EC pills market in Americas ($ millions)
  • Exhibit 09: EC pills market in EMEA ($ millions)
  • Exhibit 10: EC pills market in APAC ($ millions)
  • Exhibit 11: Global EC pills market by region
  • Exhibit 12: Global EC pills market by countries 2015
  • Exhibit 13: Global EC pills market by countries 2015-2020
  • Exhibit 14: EC pills market in the US 2015-2020 ($ millions)
  • Exhibit 15: EC pills market in China 2015-2020 ($ millions)
  • Exhibit 16: EC pills market in India 2015-2020 ($ millions)
  • Exhibit 17: Unplanned pregnancies by region ($ millions)
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Allergan: Key takeaways
  • Exhibit 21: Lupin Pharmaceuticals: Key takeaways
  • Exhibit 22: Mankind Pharma: Key takeaways
  • Exhibit 23: Piramal Healthcare: Key takeaways
  • Exhibit 24: Teva Pharmaceuticals: Business segmentation by revenue 2014
  • Exhibit 25: Teva Pharmaceuticals: Key takeaways
Back to Top